Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Updated recommendations on the use of meningococcal vaccines. Pediatrics 2014 Aug;134(2):400-3

Date

07/30/2014

Pubmed ID

25070306

DOI

10.1542/peds.2014-1383

Scopus ID

2-s2.0-84905246933 (requires institutional sign-in at Scopus site)   19 Citations

Abstract

Since the last policy statement from the American Academy of Pediatrics (AAP) concerning meningococcal vaccine was published in 2011, 2 meningococcal conjugate vaccines have been licensed for use in infants (Hib-MenCY-TT and MenACWY-CRM). The Centers for Disease Control and Prevention (CDC) has published new recommendations, "Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices," which have been endorsed by the AAP. However, the CDC recommendations were published before licensure of MenACWY-CRM for infant use. This policy statement updates the AAP recommendations for use of meningococcal vaccines in children and adolescents. A more comprehensive review of background and technical information can be found in the CDC publication.

Author List

American Academy of Pediatrics Committee on Infectious Diseases

Author

Rodney E. Willoughby MD Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Child
Child, Preschool
Contraindications
Drug Industry
Humans
Immunization Schedule
Infant
Meningococcal Vaccines
Neisseria meningitidis
Serotyping
Vaccines, Conjugate